AG
HZNP

Advisor Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Advisor Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$446K Buy
12,356
+3,060
+33% +$93.8K ﹤0.01% 1753
2019
Q3 		$253K Buy
9,296
+272
+3% +$7.03K ﹤0.01% 2146
2019
Q2 		$217K Buy
9,024
+1,432
+19% +$36.3K ﹤0.01% 2247
2019
Q1 		$200K Sell
7,592
-986
-11% -$23.4K ﹤0.01% 2288
2018
Q4 		$168K Sell
8,578
-1,804
-17% -$35.4K ﹤0.01% 2223
2018
Q3 		$203K Buy
10,382
+7,054
+212% +$134K ﹤0.01% 2154
2018
Q2 		$55K Buy
3,328
+717
+27% +$10.9K ﹤0.01% 3031
2018
Q1 		$37K Sell
2,611
-1,000
-28% -$14.8K ﹤0.01% 3305
2017
Q4 		$53K Sell
3,611
-696
-16% -$9.78K ﹤0.01% 3048
2017
Q3 		$56K Sell
4,307
-184
-4% -$2.34K ﹤0.01% 2866
2017
Q2 		$53K Buy
4,491
+2,192
+95% +$27.3K ﹤0.01% 2814
2017
Q1 		$33K Sell
2,299
-1,441
-39% -$23.3K ﹤0.01% 3022
2016
Q4 		$60K Sell
3,740
-383
-9% -$6.95K ﹤0.01% 2470
2016
Q3 		$74K Buy
4,123
+1,805
+78% +$35.3K ﹤0.01% 2236
2016
Q2 		$37K Buy
+2,318
New +$37.5K ﹤0.01% 2643

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisor Group's HZNP Position: Q4 2019 in Review

Advisor Group increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 33% in Q4 2019, buying an estimated $93.8K and bringing the position to 12,356 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Advisor Group first reported a position in HZNP in Q2 2016 and has held it in 15 quarters since. 281 funds tracked by Wall St. Rank hold HZNP as of Q4 2019.

  • Advisor Group held 12,356 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $446K as of Q4 2019.
  • Advisor Group bought 3,060 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2019, an estimated $93.8K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1753 holding.
  • Advisor Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and has held it in 15 quarters since.
  • 281 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.